A Novel A‐Kinase‐Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series
Molecular Genetics & Genomic Medicine · 2026
DOI: 10.1002/mgg3.70159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2026. Verfasst von Yuemiao Jiao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: A Kinase Anchor Proteins, Coronary Artery Disease. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Familial premature coronary artery disease (CAD) is often associated with genetic variants. This study investigated potential causal variants in a Chinese pedigree with premature CAD.
Methods
In total, nine family members were included in the study (six CAD patients and three unaffected controls). Whole‐exome sequencing (WES) was performed on six family members (including four patients and two unaffected controls), and the candidate variant was further validated by Sanger sequencing in four individuals.
Results
A strong linkage between c.6406C>G (p.Gln2136Glu; NM_005751.5) in AKAP9 (A‐KINASE ANCHOR PROTEIN 9; OMIM 604001) and premature CAD was detected in the pedigree. Functional analysis revealed that the c.6406C>G variant in AKAP9 decreased the interaction between AKAP9 and PRKAR2A. This association was first detected in premature CAD patients.
Conclusions
Our findings indicate that c.6406C>G in the AKAP9 gene could be a causal variant for premature CAD in the Chinese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Interventional Center of Valvular Heart Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- National Genomics Data Center, China National Center for Bioinformation, Beijing, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China.
- State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College and Beijing Key Laboratory of Drug Target…
- School of Sport Science, Beijing Key Laboratory of Sports Function Assessment and Technical Analysis, Beijing Sport University, Beijing, China.
ORCID-Profile: Yue Yu
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Jiao, Y., Wang, M., Qiang, G., Zhao, L., Xi, Z., Yu, Y., Yin, C., & Song, G. (2026). A Novel A‐Kinase‐Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70159
Vancouver
Jiao Y, Wang M, Qiang G, Zhao L, Xi Z, Yu Y, et al. A Novel A‐Kinase‐Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series. Molecular Genetics & Genomic Medicine. 2026. doi:10.1002/mgg3.70159
BibTeX
@article{Jiao2026,
author = {Jiao, Yuemiao and Wang, Minxian and Qiang, Guifen and Zhao, Li and Xi, Ziwei and Yu, Yue and Yin, Chengqian and Song, Guangyuan},
title = {A Novel A‐Kinase‐Anchoring Protein 9 Variant in Premature Coronary Artery Disease: A Case Series},
journal = {Molecular Genetics & Genomic Medicine},
year = {2026},
doi = {10.1002/mgg3.70159}
}
EUVIMED